These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21784490)

  • 21. A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial.
    Wolters T; Roobol MJ; van Leeuwen PJ; van den Bergh RC; Hoedemaeker RF; van Leenders GJ; Schröder FH; van der Kwast TH
    J Urol; 2011 Jan; 185(1):121-5. PubMed ID: 21074212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reply to Kwang Hyun Kim and Koon Ho Rha's letter to the editor Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 2013;63:450-8.
    Tosco L; Van den Bergh L; Joniau S
    Eur Urol; 2013 Sep; 64(3):e57-8. PubMed ID: 23769590
    [No Abstract]   [Full Text] [Related]  

  • 23. Re: Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. P. E. van Kerrebroeck, A. C. van Voskuilen, J. P. Heesakkers, A. A. Lycklama a Nijholt, S. Siegel, U. Jonas, C. J. Fowler, M. Fall, J. B. Gajewski, M. M. Hassouna, F. Cappellano, M. M. Elhilali, D. F. Milam, A. K. Das, H. E. Dijkema and U. van den Hombergh. J Urol 2007; 178: 2029-2034.
    Reynolds WS; Bales GT
    J Urol; 2008 Jun; 179(6):2483-4; author reply 2484. PubMed ID: 18436258
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: A Urine Based Genomic Assay to Triage Patients with Hematuria for CystoscopyK. E. M. van Kessel, J. J. de Jong, A. C. J. Ziel-van der Made, H. Roshani, S. M. Haensel, J. H. Wolterbeek, E. R. Boevé, E. H. G. M. Oomens, N. J. van Casteren, M. Krispin, J. L. Boormans, E. W. Steyerberg, W. van Criekinge and E. C. Zwarthoff
    Yin G; Tang J; Wang L
    J Urol; 2020 Nov; 204(5):1062. PubMed ID: 32628098
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Factors predicting prostatic biopsy Gleason sum under grading: D. A. Stackhouse, L. Sun, F. R. Schroeck, J. Jayachandran, A. A. Caire, C. O. Acholo, C. N. Robertson, D. M. Albala, T. J. Polascik, C. F. Donatucci, K. E. Maloney and J. W. Moul J Urol 2009; 182: 118-124.
    Labanaris AP; Kühn R; Zugor V
    J Urol; 2010 Jan; 183(1):396-7; author reply 397-8. PubMed ID: 19945124
    [No Abstract]   [Full Text] [Related]  

  • 26. Re: The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate BiopsiesA. Amin, M. J. Scheltema, R. Shnier, A. Blazevski, D. Moses, T. Cusick, A. Siriwardena, B. Yuen, P. J. van Leeuwen, A. M. Haynes, J. Matthews, P. Brenner, G. O'Neill, C. Yuen, W. Delprado, P. Stricker and J. Thompson
    Montorsi F; Gandaglia G; Fossati N; Briganti A
    J Urol; 2020 Oct; 204(4):843. PubMed ID: 32609573
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711: Would You Play a Russian Roulette-type Game of Prostate-specific Antigen Screening on Yourself?
    Takahashi T
    Eur Urol; 2022 Jan; 81(1):e22. PubMed ID: 34716050
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: Hessels D, Klein Gunnewiek JMT, van Oort I, Karthaus HFM, van Leenders GJL, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44:8-16.
    Jung M; Xu C; Spethmann J; Johannsen M; Deger S; Stephan C; Loening SA; Jung K
    Eur Urol; 2004 Aug; 46(2):271-2. PubMed ID: 15245824
    [No Abstract]   [Full Text] [Related]  

  • 29. Re: Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above: A. Vickers, E. A. Vertosick, D. D. Sjoberg, M. J. Roobol, F. Hamdy, D. Neal, A. Bjartell, J. Hugosson, J. L. Donovan, A. Villers, S. Zappala and H. Lilja J Urol 2017;197:607-613.
    Shah N; Ioffe V
    J Urol; 2017 Aug; 198(2):445-446. PubMed ID: 28457843
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019;76:871.
    Cimadamore A; Scarpelli M; Cheng L; Lopez-Beltran A; Galosi AB; Montorsi F; Montironi R
    Eur Urol; 2020 May; 77(5):e122-e127. PubMed ID: 32089357
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Henk G. van der Poel, Tessa Buckle, Oscar R. Brouwer, Renato A. Valdés Olmos, Fijs W.B. van Leeuwen. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol 2011;60:826-33.
    Polom K; Murawa D; Polom W
    Eur Urol; 2012 Mar; 61(3):e18; author reply e19-20. PubMed ID: 22178215
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2021;79:243-62: Comorbidity Measurement in Patients with Prostate Cancer.
    Froehner M; Koch R; Graefen M
    Eur Urol; 2021 May; 79(5):e138. PubMed ID: 33612374
    [No Abstract]   [Full Text] [Related]  

  • 33. Reply to Takeshi Takahashi's Letter to the Editor re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711: Would You Play a Russian Roulette-type Game of Prostate-specific Antigen Screening on Yourself?
    Van Poppel H; Roobol MJ
    Eur Urol; 2022 Jan; 81(1):e23-e24. PubMed ID: 34756628
    [No Abstract]   [Full Text] [Related]  

  • 34. Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol 2021;79:263-82.
    von Eyben FE
    Eur Urol; 2021 Jun; 79(6):e176. PubMed ID: 33712301
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: Joris G. Heetman, Lieke Wever, Leonor J. Paulino Pereira, Roderick C.N. van den Bergh. Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era? Eur Urol Open Sci 2022;44:30-2:
    Ram P
    Eur Urol Open Sci; 2022 Dec; 46():151-152. PubMed ID: 36420116
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Smaller prostate size predicts high grade prostate cancer at final pathology. M. R. Newton, S. Phillips, S. S. Chang, P. E. Clark, M. S. Cookson, R. Davis, J. H. Fowke, S. D. Herrell, R. Baumgartner, R. Chan, V. Mishra, J. D. Blume, J. A. Smith, Jr. and D. A. Barocas. J Urol 2010; 184: 930-937.
    Calışkan S
    J Urol; 2011 Apr; 185(4):1537-8; author reply 1538. PubMed ID: 21349547
    [No Abstract]   [Full Text] [Related]  

  • 37. Commentary on "Integrative clinical genomics of advanced prostate cancer". Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, Vats P, Kunju LP, Hussain M, Feng FY, Tomlins SA, Cooney KA, Smith DC, Brennan C, Siddiqui J, Mehra R, Chen Y, Rathkopf DE, Morris MJ, Solomon SB, Durack JC, Reuter VE, Gopalan A, Gao J, Loda M, Lis RT, Bowden M, Balk SP, Gaviola G, Sougnez C, Gupta M, Yu EY, Mostaghel EA, Cheng HH, Mulcahy H, True LD, Plymate SR, Dvinge H, Ferraldeschi R, Flohr P, Miranda S, Zafeiriou Z, Tunariu N, Mateo J, Perez-Lopez R, Demichelis F, Robinson BD, Schiffman M, Nanus DM, Tagawa ST, Sigaras A, Eng KW, Elemento O, Sboner A, Heath EI, Scher HI, Pienta KJ, Kantoff P, de Bono JS, Rubin MA, Nelson PS, Garraway LA, Sawyers CL, Chinnaiyan AM.Cell. 21 May 2015;161(5):1215-1228.
    Freedland SJ; Aronson WJ
    Urol Oncol; 2017 Aug; 35(8):535. PubMed ID: 28623072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reply to Michael Froehner, Rainer Koch, and Markus Graefen's Letter to the Editor re: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2021;79:243-62. Comorbidity Measurement in Patients with Prostate Cancer.
    van den Bergh RCN; O'Hanlon S; Cornford P; Mottet N;
    Eur Urol; 2021 May; 79(5):e139-e140. PubMed ID: 33608157
    [No Abstract]   [Full Text] [Related]  

  • 39. Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is Limited.
    Capitanio U; Autorino R; Bandini M; Briganti A; Cheng L; Cooperberg MR; Dehò F; Gallina A; Klotz L; Lane BR; Montironi R; Salonia A; Stief C; Tombal B; Montorsi F
    Eur Urol Oncol; 2022 Apr; 5(2):261-262. PubMed ID: 34083164
    [No Abstract]   [Full Text] [Related]  

  • 40. Re: Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1% K. Touijer, F. Rabbani, J. R. Otero, F. P. Secin, J. A. Eastham, P. T. Scardino And B. Guillonneau J Urol 2007; 178: 120-124.
    Joseph JV; Greene T
    J Urol; 2008 Feb; 179(2):789-90. PubMed ID: 18082824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.